Keith L. Ligon

Affiliations: 
Pathology Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States 
Google:
"Keith Ligon"
Bio:

MD PhD

BRIGHAM & WOMEN'S HOSP
PATHOLOGY DEPT AMORY 3.121
75 FRANCIS ST
BOSTON, MA 21156106
United States

Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mittal K, Cooper GW, Lee BP, et al. (2024) Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin. Communications Biology. 7: 426
Finotto L, Cole B, Giese W, et al. (2023) Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma. Embo Molecular Medicine. e18144
Aquilanti E, Kageler L, Watson J, et al. (2023) Telomerase inhibition is an effective therapeutic strategy in TERT promoter mutant-glioblastoma models with low tumor volume. Neuro-Oncology
Giannikou K, Zhu Z, Kim J, et al. (2020) Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc
Alexandrescu S, Meredith DM, Lidov HG, et al. (2020) Loss of H3K27me3 and nuclear expression of TLE1 in primary intracranial sarcoma, DICER1-mutant. Histopathology
Torre M, Vasudevaraja V, Serrano J, et al. (2020) Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Acta Neuropathologica Communications. 8: 107
Gojo J, Englinger B, Jiang L, et al. (2020) Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma. Cancer Cell. 38: 44-59.e9
Mineo M, Lyons SM, Zdioruk M, et al. (2020) Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus. Molecular Cell
Rahman R, Trippa L, Alden S, et al. (2020) Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide. International Journal of Radiation Oncology, Biology, Physics
Touat M, Li YY, Boynton AN, et al. (2020) Mechanisms and therapeutic implications of hypermutation in gliomas. Nature. 580: 517-523
See more...